Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia

Shahina Daar*, Anil Pathare, Hanspeter Nick, Ulrike Kriemler-Krahn, Abdel Hmissi, Dany Habr, Ali Taher

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

59 Citations (Scopus)

Fingerprint Dive into the research topics of 'Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences